Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma

Pathology and Oncology Research

Volumn 17, Issue 1, 2011, Pages 141-143

  Demeter, Judit ^a   Istenes, Ildiko ^a   Fodor, Anikó ^a   Paksi, Melinda ^a   Dombi, Peter ^b   Valasinyószki, Erika ^b   Csomor, Judit ^a   Matolcsy, András ^a   Nagy, Zsolt G ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b St Borbala Hospital   (Hungary)

Author keywords

Chemotherapy; Lymphoma; Romiplostim; Thrombocytopenia

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXORUBICIN; ERYTHROPOIETIN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; ROMIPLOSTIM; VINCRISTINE;

ADULT; ANAMNESIS; ARTICLE; BETA THALASSEMIA; BLOOD EXAMINATION; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHEMOTHERAPY INDUCED THROMBOCYTOPENIA; CLINICAL EXAMINATION; CYTOKINE RELEASE SYNDROME; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; GASTROINTESTINAL HEMORRHAGE; GASTROSCOPY; HEMATOLOGICAL PARAMETERS; HUMAN; HYPERTENSION; JAUNDICE; JEHOVAH'S WITNESS; LEUKEMIA; LIVER BIOPSY; LYMPHADENOPATHY; MALE; MANTLE CELL LYMPHOMA; SPLENOMEGALY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOCYTOSIS;

ANTINEOPLASTIC AGENTS; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; RECEPTORS, FC; RECOMBINANT FUSION PROTEINS; THROMBOCYTOPENIA; THROMBOPOIETIN;

EID: 79952708586     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-010-9276-4     Document Type: Article

References (5)

1. Levy B, Arnason JE, Bussel JB (2008) The use of secondgeneration thrombopoietic agents for chemotherapy-induced thrombocytopenia. Curr Opin Oncol 20:690-696
2. Natale R, Charu V, Schütte W et al (2009) Safety of romiplostim for treatment of chemotherapy-induced thrombocytopenia (CIT) in patients with advanced non-small cell lung cancer (NSCLC). Eur J Cancer Suppl 7:574
3. Fanale M, Stiff P, Noonan K et al (2009) Safety of romiplostim for treatment of severe chemotherapy induced thrombocytopenia (CIT) in patients with lymphoma receiving multi-cycle chemotherapy: results from an open-label dose- and schedule-finding study. Eur J Cancer Suppl 7:562
4. Dalal S, Boddapati M, Lowery MN et al (2006) Treatment of acute myeloid leukemia in a Jehovah's Witness. Ann Hematol 85:407-408
5. Nash MJ, Cohen H (2004) Management of Jehovah's Witness patients with haematological problems. Blood Rev 18:211-7 (Pubitemid 38859630)